Physician profile
Nesreen Hermes
NPI 1346516655
$1,893.40
in general payments reported to CMS, 2019-2025
19 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $52.42 · 2021: $250 · 2022: $596 · 2023: $372 · 2024: $305 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $962.95 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $949.46 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $128.34 | 2022-2024 | |
| Pfizer INC. | $119.95 | 2024-2025 | |
| Exact Sciences Corporation | $107.94 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $101.65 | 2022-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $94.68 | 2023-2025 | |
| Phadia US INC. | $64.08 | 2021-2024 | Immunocap |
| Hologic Sales and Service, LLC | $60.96 | 2020-2024 | Aptima |
| Avion Pharmaceuticals | $53.61 | 2022-2023 | Divigel |
| Biohaven Pharmaceutical Holding Company LTD. | $47.23 | 2022 | |
| Depuy Synthes Sales INC. | $23.22 | 2024 | Monovisc |
| Alexion Pharmaceuticals, INC. | $20.65 | 2023 | Strensiq |
| Cranial Technologies, INC | $20.34 | 2024 | Doc Band |
| Organon LLC | $18.71 | 2022 | |
| Echosens North America, INC. | $17.65 | 2025 | Fibroscan |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $17.46 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.06 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.46 | 2020 | |
| Xeris Pharmaceuticals, INC. | $14.95 | 2025 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nesreen Hermes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.